Results of the citalopram to enhance cognition in Huntington disease trial.
about
Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations.Therapeutic advances in Huntington's Disease.Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?Systematic review of pharmacological treatments for depressive symptoms in Huntington's disease.Current therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches?Practice Effects and Stability of Neuropsychological and UHDRS Tests Over Short Retest Intervals in Huntington Disease.Advancing pharmacotherapy for treating Huntington's disease: a review of the existing literature.Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts.Huntington's Disease-Update on Treatments.Psychiatric comorbidities in movement disorders.Overstatements in abstract conclusions claiming effectiveness of interventions in psychiatry: A meta-epidemiological investigation.Potential implications of practice effects in Alzheimer's disease prevention trials.Rating scales for cognition in Huntington's disease: Critique and recommendations.Therapy development in Huntington disease: From current strategies to emerging opportunities.Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations
P2860
Q30249645-DB9C94B5-774D-45F8-A83A-F1CA7C35FB41Q34487604-0EAAF8F1-23AA-4DC3-9294-326025DB1D78Q35158376-B1064143-389F-40B6-88FF-742B20F9A1FCQ38238894-A4E21905-172B-4100-93CE-55C85EA33337Q38244078-48C1270A-691F-4431-B55D-C27CA92ED112Q38402339-3B97C427-9D97-4DD9-83DC-1FEA1926A723Q38624994-E3452329-4DA1-4990-9601-CC01DB7628C7Q38792714-CC50C9CD-7E79-4A1F-9B47-C3E5076416A6Q39190617-4814C95F-ED5D-411C-98F8-53D02E342A31Q39417632-62D88BFA-F49E-4F90-AFDD-FC1780FE29FBQ41140653-F9792EBA-B909-4500-B17E-C5020903D580Q46493022-567691A5-C5A8-40E6-A963-B97C946C31BEQ47219147-FF4F3617-5C52-44CE-AFEC-5718B4E7D50AQ53716390-F53CB54D-9059-43B5-A4F4-51AA5E3AC04BQ58574520-70DCA4B6-C9B1-462C-9153-2840E6469930
P2860
Results of the citalopram to enhance cognition in Huntington disease trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Results of the citalopram to enhance cognition in Huntington disease trial.
@en
Results of the citalopram to enhance cognition in Huntington disease trial.
@nl
type
label
Results of the citalopram to enhance cognition in Huntington disease trial.
@en
Results of the citalopram to enhance cognition in Huntington disease trial.
@nl
prefLabel
Results of the citalopram to enhance cognition in Huntington disease trial.
@en
Results of the citalopram to enhance cognition in Huntington disease trial.
@nl
P2093
P2860
P50
P356
P1433
P1476
Results of the citalopram to enhance cognition in Huntington disease trial.
@en
P2093
Blair Olson
John Caviness
Kevin Biglan
Leigh J Beglinger
Ricardo Jorge
Robert G Robinson
William H Adams
P2860
P304
P356
10.1002/MDS.25750
P407
P577
2013-12-27T00:00:00Z